A9599 — Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
A9599 is a HCPCS Level II code for radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified. It belongs to the Transportation, Medical & Surgical Supplies, Administrative section. It was terminated on December 31, 2017 and is not valid on new claims.
This code has been terminated
CMS terminated A9599 on December 31, 2017. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for A9599
- Long descriptor
- Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
- Short descriptor
- Radioph dx b amyloid pet nos
- Added
- January 1, 2014
- Terminated
- December 31, 2017
- BETOS
- I1E
- Pricing indicator
- 57 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Other carrier priced.
Codes adjacent to A9599
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If A9599 is not quite right, the correct code is very often within a few positions of it.
- A9591Fluoroestradiol f 18, diagnostic, 1 millicurie
- A9592Copper cu-64, dotatate, diagnostic, 1 millicurie
- A9593Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie
- A9594Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie
- A9595Piflufolastat f-18, diagnostic, 1 millicurie
- A9596Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie
- A9597Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified
- A9598Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classified
- A9600Strontium sr-89 chloride, therapeutic, per millicurie
- A9601Flortaucipir f 18 injection, diagnostic, 1 millicurie
- A9602Fluorodopa f-18, diagnostic, per millicurie
- A9603Injection, pafolacianine, 0.1 mg
- A9604Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
- A9606Radium ra-223 dichloride, therapeutic, per microcurie
- A9607Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
- A9608Flotufolastat f 18, diagnostic, 1 millicurie
Questions about A9599
What is HCPCS code A9599?
A9599 is a HCPCS Level II code for radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified. It sits in the Transportation, Medical & Surgical Supplies, Administrative section.
Does Medicare cover A9599?
The CMS HCPCS file marks A9599 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is A9599 still valid?
No. A9599 was terminated on December 31, 2017 and should not be used on new claims.